Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Food and Drug Administration (FDA)
Pharma
Lack of global regulatory alignment spurs bad actors, FDA says
If a gene therapy is approved in the U.S., patients in Brazil can sue for access. It’s why global regulators need to work together, Peter Marks said.
Annalee Armstrong
May 9, 2024 10:15am
Pharma heads for cancer first line, causing early-stage rethink
Nov 17, 2023 3:00am
Biogen, FDA's unusual Aduhelm coordination revealed: report
Dec 29, 2022 3:28pm
FDA slaps clinical hold on Pharvaris' HAE med
Aug 22, 2022 9:58am
Ardelyx's last ditch tenapanor appeal successful
Apr 25, 2022 10:44am
